期刊文献+

CAPD患者肌少症的发生情况及相关因素分析 被引量:1

Analysis of the occurrence and related factors of sarcopenia in patients with CAPD
下载PDF
导出
摘要 目的探讨持续非卧床腹膜透析(CAPD)患者肌少症与非肌少症发生情况及危险因素。方法选取2019年8月至2020年8月规律接受CAPD治疗时间>3个月、资料完整患者123例。采用主观综合营养评估(subjective global assessment,SGA)法评估患者营养状况,肌少症的诊断采用最新EWGSOP 2法评价,并收集患者的一般情况及血生化指标。按照有无肌少症分为肌少症组(25例)和无肌少症组(98例),对比2组患者临床资料和生化指标情况,应用二元Logistic回归模型法探讨影响CAPD患者肌少症的相关因素。结果123例CAPD患者中存在肌少症25例,患病率为20.33%。2组患者的年龄、透析龄、SGA、HGS、LTI、FTI、E/I、BMI、ALB、25(OH)D、hs-CPR、GLU差异有统计学意义(P<0.05),而性别、HBG、TCH、TG、Ca、P、PTH、RRF2组间差异无统计学意义(P>0.05)。二元Logistic回归分析结果显示,年龄、透析龄、SGA、HGS、LTI、BMI、hs-CPR是腹透患者发生肌少症的相关因素。结论腹透患者肌少症比较多见,年龄、透析龄、SGA、HGS、LTI、BMI、hs-CRP是腹透患者发生肌少症的相关因素。 Objective To investigate the occurrence and risk factors of sarcopenia and non-sarcopenia in patients with Continuous Ambulatory Peritoneal Dialysis(CAPD).Methods A total of 123 patients with were treated by CAPD for>3 months in our hospital from August 2019 to August 2020 were enrolled in the study.The nutritional status of patients was assessed by Subjective Global Assessment(SGA),and the diagnosis of sarcopenia was evaluated by the latest EWGSOP 2 method,and the general situation and blood biochemical indicators of patients were collected.Moreover the patients with sarcopenia were divided into sarcopenia group(n=25)and non-sarcopenia group(n=98)according to the presence or absence of sarcopenia.The clinical data and biochemical parameters were observed and compared between the two groups.In addition the related factors of sarcopenia in patients with CAPD were analyzed by binary Logistic regression model.Results Of the 123 patients with CAPD patients,there were 25 cases of sarcopenia,with the prevalence rate being 20.33%.There were significant differences in patient’s age,dialysis duration,and the levels of SGA,HGS,LTI,FTI,E/I,BMI,ALB,25(OH)D,hs-CPR and GLU between the two groups(P<0.05).However there were no significant differences in patient’s gender,and the levels of HBG,TCH,TG,Ca,P,PTH and RRF between the two groups(P>0.05).Binary Logistic regression analysis showed that age,dialysis duration,SGA,HGS,LTI,BMI,and HS-CPR were the related factors with the occurrence of sarcopenia in patients with peritoneal dialysis.Conclusion Sarcopenia is more common in patients with peritoneal dialysis,and age,dialysis duration,SGA,HGS,LTI,BMI and Hs-CRP are the related factors with the occurrence of sarcopenia in patients with peritoneal dialysis.
作者 贾兰芳 李雪梦 王欢欢 孙秀娜 韩昊洲 王景福 王波 JIA Lanfang;LI Xuemeng;WANG Huanhuan(Affiliated Hospital of Chengde Medical University,Hebei,Chengde 067000,China)
出处 《河北医药》 CAS 2022年第17期2579-2582,共4页 Hebei Medical Journal
基金 河北省医学科学研究课题计划(编号:20200374)。
关键词 腹膜透析 肌少症 发生情况 相关因素 peritoneal dialysis sarcopenia occurrence related factors
  • 相关文献

参考文献3

二级参考文献35

  • 1Andreas Vychytil,Manuela F?dinger,Johannes Pleiner,et al.Acute effect of amino acid peritoneal dialysis solu-tion on vascular Function[].The American Journal of Clinical Nutrition.2003
  • 2Asola M,Virtanen K,Nagren K, et al.Amino-acid-based peritoneal dialysis solution improves amino-acid transport into skeletal muscle[].Kidney International Supplement.2008
  • 3Lindholm B,Alrestrand A,Fürst P,et al.Plasma and musclefreeamino acids during continuous ambulatoryperitonealdialysis[].Kidney International.1989
  • 4Deferrari G,Garibotto G,Robaudo C,et al.Abnormalities inblood amino acid profile after a protein meal in patientswithchronic renal failure[].Kidney International.1989
  • 5Dombros NV,Digenis GE,Oreopoulos DG.Nutritional markers aspredictors of survival in patients on CAPD[].Peritoneal DialysisInternatsonal.1995
  • 6Kuhlmann MK,Kopple JD.Amino acid metabolism in thekidney[].Seminars in Nephrology.1990
  • 7Marcel CG van de Poll,Peter B Soeters,Nicolaas,EP Deutz,et al.Renal metabolism of amino acids:its role in interorgan aminoacid exchange 1’’2’’3’’[].The American Journat of ClinicalNutrition.2004
  • 8A Sayer A, Stewart C, Patel H, et al. The developmental origins of sarcopenia: from epidemiological evidence to underlying mechanisms. J Dev Orig Health Dis,2010,1 (3) :150-157.
  • 9Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc, 2004, 52 ( 1 ) : 80-85.
  • 10Domaflski M ,Ciechanowski K.Sarcopenia: a major challenge in elderly patients with end-stage renal diseasc.J Aging Res ,2012,2012:754739.

共引文献334

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部